Effect of tauro-α-muricholate and tauro-β-muricholate on oestradiol- 17β-glucuronide induced cholestasis in rats

Journal of Gastroenterology and Hepatology (Australia)

Volumn 12, Issue 1, 1997, Pages 84-86

  Takikawa, Hajime ^a   Sano, Naoyo ^a   Aiso, Mitsuhiko ^a   Takamori, Yoriyuki ^a   Yamanaka, Masami ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Bile acid; Cholestasis; Oestradiol 17 glucuronide; Tauro muricholate; Tauro muricholate; Tauroursodeoxycholate

Indexed keywords

BILE ACID; ESTRADIOL; ESTRADIOL 17 GLUCURONIDE; TAURO ALPHA MURICHOLIC ACID; TAURO BETA MURICHOLIC ACID; TAUROURSODEOXYCHOLIC ACID; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTASIS; CONTROLLED STUDY; HUMAN; MALE; PRIORITY JOURNAL; RAT;

EID: 0031038555     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1746.1997.tb00352.x     Document Type: Article

References (13)

1. Kitani K, Kanai S. Tauroursodeoxycholate prevents taurocholate induced cholestasis. Life Sci. 1982; 30: 515-23.
2. Schölmerich J, Baumgartner U, Miyai K, Gerok W. Tauroursodeoxycholate prevents taurolithocholate-induced cholestasis in rat liver. J. Hepatol. 1990; 10: 280-3.
3. Heuman DM, Mills AS, McCall J, Hylemon PB, Pandak WM, Vlahcevic ZR. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more Hydrophobic bile salts. In vivo studies in the rat. Gastroenterology 1991; 100: 203-11.
4. Takikawa H, Minagawa K, Sano N, Yamanaka M. Lithocholate-3-O-glucuronide-induced cholestasis. A study with congenital hyperbilirubinemic rats and effects of ursodeoxycholate conjugates. Dig. Dis. Sci. 1993; 38: 1543-8.
5. Ohiwa T, Katagiri K, Hoshino M, Hayakawa T, Nakai T. Tauroursodeoxycholate and tauro-β-muricholate exert cytoprotection by reducing intrahepatic taurochenodeoxycholate content. Hepatology 1993; 17: 470-6.
6. Utili R, Tripodi MF, Adinolfi LE, Gaeta GB, Abernathy CO, Zimmerman HJ. Estradiol-17β-D-glucuronide (E-17G) cholestasis in perfused rat liver: Fate of E-17G and choleretic responses to bile salts. Hepatology 1990; 11: 735-42.
7. Sano N, Takikawa H, Yamanaka M. Estradiol-17β-glucuronide-induced cholestasis. Effects of ursodeoxycholate-3-O-glucuronide and 3,7-disulfate. J. Hepatol. 1993; 17: 241-6.
8. Kanai S, Ohta M, Kitani K, Sato Y. Tauro-β-muricholate is as effective as tauroursodeoxycholate in preventing taurochenodeoxycholate-induced liver damage in the rat. Life Sci. 1990; 47: 2421-8.
9. Kitani K, Kahai S, Sato Y, Ohta M. Tauro-α-muricholate is as effective as tauro-β-muricholate in preventing taurochenodeoxycholate-induced liver damage in the rat. Hepatology 1994; 19: 1007-12.
10. Meyers M, Slikker W, Pascoe G, Vore M. Characterization of cholestasis induced by estradiol-17β-D-glucuronide in the rat. J. Pharmacol. Exp. Ther. 1980; 214: 87-93.
11. Kan KS, Monte MJ, Parslow RA, Coleman R. Oestradiol 17β-glucuronide increases tight-junctional permeability in rat liver. Biochem. J. 1989; 261: 297-300.
12. Alvaro D, Angelico M, Cantafora A et al. Improvement of estradiol-17β-glucuronide cholestasis by intravenous administration of dimethylethanolamine in the rat. Hepatology 1991; 13: 1158-72.
13. Takikawa H, Yamazaki R, Sano N, Yamanaka M. Biliary excretion of estradiol-17β-glucuronide in the rat. Hepatology 1996; 23: 607-13.